Key result
Implantable cardioverter defibrillators and beta-blockers are effective for the treatment and prevention of sudden cardiac death in high-risk populations.
Why the study?
Do implantable cardioverter defibrillators and beta-blockers prevent sudden cardiac death in high-risk patients?
Do implantable cardioverter defibrillators and beta-blockers prevent sudden cardiac death in high-risk patients?
This review highlights that ICDs and beta-blockers are the most effective therapies for preventing sudden cardiac death, while most antiarrhythmic drugs lack mortality benefit.
No takes yet. Share an insight, caveat, or question.
Supports prioritizing ICDs and beta-blockers for SCD prevention in high-risk patients; leaves open optimal selection and comparative effectiveness questions.
Jeffrey J. Goldberger (1999) conducted a review in Sudden cardiac death. Implantable cardioverter defibrillators and beta-blockers was evaluated. Implantable cardioverter defibrillators and beta-blockers are effective for the treatment and prevention of sudden cardiac death in high-risk populations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: